Today: 27 June 2026
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

NEW YORK, June 27, 2026, 11:01 EDT

  • Uber climbed 5.47% on Friday, closing at $76.20 while the Nasdaq Composite slipped 0.24%.
  • About 64.58 million shares changed hands Friday, nearly three and a half times the 65-day average. That worked out to roughly $4.9 billion in stock at the close.
  • This week U.S. equities trade for four sessions, with NYSE and Nasdaq shut July 3 for the Independence Day holiday.

Uber Technologies got a big lift to close out a rough week for tech. The stock jumped 5.47% to $76.20 on Friday, even as the Nasdaq Composite slipped 0.24%. Trading volume was 64.58 million shares, way above its 65-day average of 18.67 million. About $4.9 billion worth of UBER shares changed hands at the close.

Uber rose 6.4% from its June 18 close, right before the Juneteenth break. The Nasdaq ended down 4.6% this week, while the S&P 500 lost 2.0%. Even with the gain, Uber finished Friday 25.3% under its 52-week high at $101.99.

Investors didn’t suddenly bet on a robotaxi boom. What’s happening is buyers are sticking with Uber even as the market puts clearer numbers on two risks—higher safety costs now and robotaxi expansion in the future.

Uber is making U.S. driver background checks tougher and says the new standards cover current drivers too. Beginning Monday, the company will broaden which criminal convictions can get drivers and couriers barred, no matter how old the offense is. Bloomberg Law says Uber expects tens of thousands of gig workers—around 0.5% of its active U.S. base—to be cut.

The national count is low. For Uber, which gets priced on trips, wait times and margins, it’s not nothing. If cuts pile up in some locations or hours, Uber could face higher incentive costs or have to live with slower service.

BTIG’s Jake Fuller stuck to his Buy rating and $100 price target on Uber on Friday. That target is 31.2% over the last close, Google Finance shows. Fuller said Uber’s moves in autonomous vehicles haven’t “yet to meaningfully shift investor sentiment,” per Benzinga. He wrote that his robotaxi view is less about near-term changes. Google

BTIG says around 4,100 robotaxis are providing paid rides in 11 U.S. cities, with Waymo operating nearly 3,800 of those. About 1,000 autonomous vehicles can be hailed on the Uber app in the U.S., the firm estimated. Of those, 800 are Waymo cars and 500 can also be found on Waymo’s own app. So, Uber’s paid robotaxi supply outside Waymo is roughly 200 vehicles for now. BTIG doesn’t see that supply reaching thousands until 2027 or 2028.

Uber’s stock is set up for more debate next week. Right now, the chart shows investors are focused on its core cash generation. Autonomy is not getting much credit—at least not yet. The current math on robotaxi says the market isn’t assigning a lot of value to near-term control.

Uber has the numbers to back it up. First-quarter trips were up 20% at 3.6 billion. Gross bookings climbed 25% to $53.7 billion. Adjusted EBITDA gained 33% to $2.5 billion. Free cash flow was $2.3 billion. Uber is guiding for second-quarter gross bookings between $56.25 billion and $57.75 billion, with adjusted EBITDA of $2.70 billion to $2.80 billion.

Uber CEO Dara Khosrowshahi said Uber One members now account for about half of Gross Bookings in Mobility and Delivery. CFO Balaji Krishnamurthy said the company is keeping a “capital-efficient approach to AVs.” investor.uber.com

Markets won’t have to wait for earnings to test both claims. A safety reset kicks off Monday. With the July 3 holiday, there are four full U.S. trading sessions this week. Both NYSE and Nasdaq will close for Independence Day, according to the schedule.

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

Snowflake (NYSE:SNOW) finishes up for the week after Russell rebalance trading

27 June 2026
Snowflake Inc (NYSE:SNOW) surged 9.65% to $248.96 on Friday with trading volume five times the weekly average, driven by FTSE Russell’s U.S. index reconstitution, turning a negative week into a 7.2% gain since June 18, as investors await whether the stock can hold above its previous $225.95–$230.41 range when index-driven liquidity fades next week.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar
Previous Story

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Go toTop